Trends in FDA Adverse Events Reporting for Inferior Vena Cava Filters and Estimated Insertions in the US, 2016 to 2020

Rachel E Warren; Sanket S Dhruva; Madris Kinard; John M Neuhaus; Rita F Redberg

doi:10.1001/jamainternmed.2022.6161

Trends in FDA Adverse Events Reporting for Inferior Vena Cava Filters and Estimated Insertions in the US, 2016 to 2020

JAMA Intern Med. 2023 Mar 1;183(3):271-272. doi: 10.1001/jamainternmed.2022.6161.

Authors

Rachel E Warren¹, Sanket S Dhruva^{2

3

4}, Madris Kinard⁵, John M Neuhaus^{4

6}, Rita F Redberg^{2

3

4

7}

Affiliations

¹ University of California, San Francisco School of Medicine, San Francisco, California.
² Department of Cardiology, University of California, San Francisco, California.
³ Institute of Health Policy Studies, University of California, San Francisco.
⁴ University of California, San Francisco.
⁵ Device Events, York, Pennsylvania.
⁶ Department of Epidemiology and Biostatistics, University of California, San Francisco.
⁷ Editor, JAMA Internal Medicine.

No abstract available

Plain language summary

This quality improvement study identifies adverse events for inferior vena cava filters and reports changes in adverse event reporting and estimated insertions between 2016 and 2020 in the US.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Device Removal
Humans
Pulmonary Embolism*
Risk Factors
Vena Cava Filters* / adverse effects